LATEST NEWS   The RM5 billion microfinancing facility announced today is separate from the RM5 billion Special SME Assistance Facility by BNM as well as the RM5 billion under the SJPP - MoF | The MADANI Government is providing micro-financing facilities totalling over RM5 billion in 2026, expected to benefit over 400,000 micro-entrepreneurs, with loans of up to RM100,000 - MoF | At 6 pm, the ringgit depreciated to 3.9300/9330 against the greenback from 3.9285/9325 at Wednesday’s close. | EG Industries Bhd wholly-owned subsidiary seals US$241.6 million purchase order for high-speed optical modules and wireless access-related products | Continued expansion in the loan and deposit portfolios lifts Public Bank's net profit to RM1.75 bln in 1Q 2026 from RM1.74 bln in 1Q 2025. | 

Wellous, Korea Ginseng Corporation Ink Partnership To Drive Health, Wellness Growth In Asia

KUALA LUMPUR, Sept 8 (Bernama) -- Wellous Sdn Bhd, owner of Malaysian health brand Wellous, has signed a memorandum of understanding (MoU) with Korea Ginseng Corporation (KGC) to explore joint commercial models and market development for the Jung Kwan Jang brand across selected Asian markets.

Jung Kwan Jang, South Korea’s No. 1 red ginseng brand under KGC, is a century-old label that combines heritage cultivation with modern innovation.

In a statement, Wellous said the collaboration covers consumer insight-sharing for target markets, co-development of new business approaches, brand reputation building, as well as authorised sales and promotion of Jung Kwan Jang products by Wellous in designated countries.

Wellous group president Tan Lee Koon said the partnership reflects the post-pandemic shift towards disease prevention and daily health management.

“Public focus on preventive care has grown markedly, with spending on prevention gradually surpassing treatment costs.

“In this context, Wellous remains committed to science-backed, effective products that help consumers of diverse cultures maintain their health in everyday life,” he said.

Backed by its medical and research board of advisors (MRBA), Wellous has developed functional foods under brands such as Tigrox, Zenso, Femoire, Aemis and Immority, guided by its mission to “make health easier”.

Jung Kwan Jang, recognised as South Korea’s flagship ginseng brand, is known for combining heritage cultivation practices with modern manufacturing controls, ranging from soil selection to cultivation and production to ensure product quality and safety.

As part of the MoU, a Wellous delegation visited Jung Kwan Jang’s headquarters, research and development centre and manufacturing facilities in South Korea recently for in-depth exchanges on corporate philosophy and product development.

Tan praised the South Korean brand’s commitment to research, product safety and consumer convenience, while Jung Kwan Jang acknowledged Wellous’ direct-to-consumer online model and differentiated services.

To drive the collaboration, Wellous has established a subsidiary, Lore Nature, to spearhead discussions and implementation.

Wellous said its international footprint now spans about 80 countries, supported by localisation strategies and global partnerships.

“The company attributes its growth to consistent product quality, a ‘prevention-first’ approach, and its ability to respond quickly to varying consumer needs through digital channels and direct engagement,” it said.

Looking ahead, Wellous said it plans to consolidate its existing markets and expand into new ones, tailoring functional foods to local cultures and consumption habits.

On environmental, social and governance (ESG) priorities, the company said it continues to pursue sustainability and wider access to health products by collaborating with partners and community initiatives, such as The Lost Food Project, DHL and the ZL Ultramarathon Charity Run.

For more information or collaboration inquiries, please email contact@lorenature.com.

-- BERNAMA

(Disclaimer: This is a paid advertorial. BERNAMA assumes no responsibility for the content, accuracy and opinions carried in the article.)